8-K/A XBRL

FORM 8-K/A

Company: NRX Pharmaceuticals, Inc.
Filed: March 14, 2023
Period of Report: March 9, 2023
Accession Number: 0001104659-23-032019

View Document ↗ View on SEC.gov ↗